These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32424618)

  • 1. De novo mutations in FBRSL1 cause a novel recognizable malformation and intellectual disability syndrome.
    Ufartes R; Berger H; Till K; Salinas G; Sturm M; Altmüller J; Nürnberg P; Thiele H; Funke R; Apeshiotis N; Langen H; Wollnik B; Borchers A; Pauli S
    Hum Genet; 2020 Nov; 139(11):1363-1379. PubMed ID: 32424618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fbrsl1 is required for heart development in Xenopus laevis and de novo variants in FBRSL1 can cause human heart defects.
    Berger H; Gerstner S; Horstmann MF; Pauli S; Borchers A
    Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38501224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing a Novel Malformation Syndrome Caused by Pathogenic Variants in
    Pauli S; Berger H; Ufartes R; Borchers A
    Front Cell Dev Biol; 2021; 9():779009. PubMed ID: 34805182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Pathogenic Variant in
    Bukvic N; De Rinaldis M; Chetta M; Trabacca A; Bassi MT; Marsano RM; Holoubkova L; Rivieccio M; Oro M; Resta N; Kerkhof J; Sadikovic B; Viggiano L
    Genes (Basel); 2024 Jun; 15(7):. PubMed ID: 39062605
    [No Abstract]   [Full Text] [Related]  

  • 5. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus.
    Beunders G; Voorhoeve E; Golzio C; Pardo LM; Rosenfeld JA; Talkowski ME; Simonic I; Lionel AC; Vergult S; Pyatt RE; van de Kamp J; Nieuwint A; Weiss MM; Rizzu P; Verwer LE; van Spaendonk RM; Shen Y; Wu BL; Yu T; Yu Y; Chiang C; Gusella JF; Lindgren AM; Morton CC; van Binsbergen E; Bulk S; van Rossem E; Vanakker O; Armstrong R; Park SM; Greenhalgh L; Maye U; Neill NJ; Abbott KM; Sell S; Ladda R; Farber DM; Bader PI; Cushing T; Drautz JM; Konczal L; Nash P; de Los Reyes E; Carter MT; Hopkins E; Marshall CR; Osborne LR; Gripp KW; Thrush DL; Hashimoto S; Gastier-Foster JM; Astbury C; Ylstra B; Meijers-Heijboer H; Posthuma D; Menten B; Mortier G; Scherer SW; Eichler EE; Girirajan S; Katsanis N; Groffen AJ; Sistermans EA
    Am J Hum Genet; 2013 Feb; 92(2):210-20. PubMed ID: 23332918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defects.
    Martinez-Delgado B; Lopez-Martin E; Lara-Herguedas J; Monzon S; Cuesta I; Juliá M; Aquino V; Rodriguez-Martin C; Damian A; Gonzalo I; Gomez-Mariano G; Baladron B; Cazorla R; Iglesias G; Roman E; Ros P; Tutor P; Mellor S; Jimenez C; Cabrejas MJ; Gonzalez-Vioque E; Alonso J; Bermejo-Sánchez E; Posada M
    Am J Med Genet A; 2021 Mar; 185(3):877-883. PubMed ID: 33346930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism.
    Fan Y; Yin W; Hu B; Kline AD; Zhang VW; Liang D; Sun Y; Wang L; Tang S; Powis Z; Li L; Yan H; Shi Z; Yang X; Chen Y; Wang J; Jiang Y; Tan H; Gu X; Wu L; Yu Y
    Am J Hum Genet; 2018 Sep; 103(3):448-455. PubMed ID: 30122539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A detailed clinical analysis of 13 patients with AUTS2 syndrome further delineates the phenotypic spectrum and underscores the behavioural phenotype.
    Beunders G; van de Kamp J; Vasudevan P; Morton J; Smets K; Kleefstra T; de Munnik SA; Schuurs-Hoeijmakers J; Ceulemans B; Zollino M; Hoffjan S; Wieczorek S; So J; Mercer L; Walker T; Velsher L; ; Parker MJ; Magee AC; Elffers B; Kooy RF; Yntema HG; Meijers-Heijboer EJ; Sistermans EA
    J Med Genet; 2016 Aug; 53(8):523-32. PubMed ID: 27075013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions and de novo mutations of SOX11 are associated with a neurodevelopmental disorder with features of Coffin-Siris syndrome.
    Hempel A; Pagnamenta AT; Blyth M; Mansour S; McConnell V; Kou I; Ikegawa S; Tsurusaki Y; Matsumoto N; Lo-Castro A; Plessis G; Albrecht B; Battaglia A; Taylor JC; Howard MF; Keays D; Sohal AS; ; Kühl SJ; Kini U; McNeill A
    J Med Genet; 2016 Mar; 53(3):152-62. PubMed ID: 26543203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.
    Machol K; Rousseau J; Ehresmann S; Garcia T; Nguyen TTM; Spillmann RC; Sullivan JA; Shashi V; Jiang YH; Stong N; Fiala E; Willing M; Pfundt R; Kleefstra T; Cho MT; McLaughlin H; Rosello Piera M; Orellana C; Martínez F; Caro-Llopis A; Monfort S; Roscioli T; Nixon CY; Buckley MF; Turner A; Jones WD; van Hasselt PM; Hofstede FC; van Gassen KLI; Brooks AS; van Slegtenhorst MA; Lachlan K; Sebastian J; Madan-Khetarpal S; Sonal D; Sakkubai N; Thevenon J; Faivre L; Maurel A; Petrovski S; Krantz ID; Tarpinian JM; Rosenfeld JA; Lee BH; ; Campeau PM
    Am J Hum Genet; 2019 Jan; 104(1):164-178. PubMed ID: 30580808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel truncating PPM1D mutation in a patient with intellectual disability.
    Porrmann J; Rump A; Hackmann K; Di Donato N; Kahlert AK; Wagner J; Jahn A; Eger I; Flury M; Schrock E; Tzschach A; Gieldon L
    Eur J Med Genet; 2019 Jan; 62(1):70-72. PubMed ID: 29758292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome.
    Jansen S; Geuer S; Pfundt R; Brough R; Ghongane P; Herkert JC; Marco EJ; Willemsen MH; Kleefstra T; Hannibal M; Shieh JT; Lynch SA; Flinter F; FitzPatrick DR; Gardham A; Bernhard B; Ragge N; Newbury-Ecob R; Bernier R; Kvarnung M; Magnusson EA; Wessels MW; van Slegtenhorst MA; Monaghan KG; de Vries P; Veltman JA; ; Lord CJ; Vissers LE; de Vries BB
    Am J Hum Genet; 2017 Apr; 100(4):650-658. PubMed ID: 28343630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AUTS2 isoforms control neuronal differentiation.
    Monderer-Rothkoff G; Tal N; Risman M; Shani O; Nissim-Rafinia M; Malki-Feldman L; Medvedeva V; Groszer M; Meshorer E; Shifman S
    Mol Psychiatry; 2021 Feb; 26(2):666-681. PubMed ID: 30953002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
    Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
    Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.
    Luco SM; Pohl D; Sell E; Wagner JD; Dyment DA; Daoud H
    BMC Med Genet; 2016 Feb; 17():15. PubMed ID: 26922654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel truncating variants expand the phenotypic spectrum of KAT6B-related disorders.
    Brea-Fernández A; Dacruz D; Eirís J; Barros F; Carracedo Á
    Am J Med Genet A; 2019 Feb; 179(2):290-294. PubMed ID: 30569622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features.
    Stankiewicz P; Khan TN; Szafranski P; Slattery L; Streff H; Vetrini F; Bernstein JA; Brown CW; Rosenfeld JA; Rednam S; Scollon S; Bergstrom KL; Parsons DW; Plon SE; Vieira MW; Quaio CRDC; Baratela WAR; Acosta Guio JC; Armstrong R; Mehta SG; Rump P; Pfundt R; Lewandowski R; Fernandes EM; Shinde DN; Tang S; Hoyer J; Zweier C; Reis A; Bacino CA; Xiao R; Breman AM; Smith JL; ; Katsanis N; Bostwick B; Popp B; Davis EE; Yang Y
    Am J Hum Genet; 2017 Oct; 101(4):503-515. PubMed ID: 28942966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated loss of the AUTS2 long isoform, brain-wide or targeted to Calbindin-lineage cells, generates a specific suite of brain, behavioral, and molecular pathologies.
    Song Y; Seward CH; Chen CY; LeBlanc A; Leddy AM; Stubbs L
    Genetics; 2024 Jan; 226(1):. PubMed ID: 37816306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exonic deletions of AUTS2 in Chinese patients with developmental delay and intellectual disability.
    Fan Y; Qiu W; Wang L; Gu X; Yu Y
    Am J Med Genet A; 2016 Feb; 170A(2):515-522. PubMed ID: 26545289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.